The Latest Breaking News from FDA

Lateral flow tests might not be as effective in the record-breaking temperatures unless users take action before using the do-it-yourself swabs

Skittles, the colorful, fruit-flavored candy, are coming under fire after a lawsuit filed in Northern California says people are tasting more than the rainbow.

Plus: The editors select their most influential post-war libertarian thinkers.

Sarepta is building a base as this biotech stock tries to convince regulators to approve its gene therapy.

I have a very nice patient who comes to appointments with questions about everything except his main medical problem. These are from his last visit:

‘Our use of titanium dioxide complies with FDA regulations,’ Mars says

WASHINGTON — Efforts in states to further restrict medication abortion face legal questions over potential conflicts with federal drug regulations.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Amgen (AMGN) has undertaken several strategic growth initiatives to capitalize on the expanding biotech industry. In addition, several FDA drug approvals and other research and development breakthroughs make it well-positioned to witness significant growth in the near term, making it an ideal candidate for investors seeking to gain exposure in…

The stock market sell-offs triggered by macroeconomic and geopolitical issues since the beginning of the year have driven many quality stocks into the oversold territory. So, it could be wise to invest in oversold stocks Gilead Sciences (GILD) and Comcast (CMCSA), which have solid rebound potential. Let’s discuss….

In 2019, Texas legalized hemp, but not marijuana. The new law led to confusion about which marijuana products are legal in Texas. Meanwhile, support for legalizing the drug remains high in polling, and other cannabis-derived products like delta-8 have emerged.